For closer investigations we focused on insulin-treated type 2 diabetes patients (diagnosed based on WHO criteria) with coexistent thyroid dysfunctions (n = 328) and additional available parameters: body height and weight, date of insulin initiation and titres of autoantibodies against glutamate decarboxylase (anti-GAD). The gene discussed is INS; the disease is type 2 diabetes mellitus.